We conclude, therefore, that the low expression of EGFL7 in the tumor cells of patients diagnosed with CRC may be associated with high expression of VEGF2, thus leading to an increase in lymphatic invasion and greater lymphangiogenesis. The gene discussed is EGFL7; the disease is neoplasm.